Health
AstraZeneca’s GLP-1 Pill Shows Promise in Trials
AstraZeneca's GLP-1 pill demonstrated potential benefits in mid-stage obesity and diabetes trials. The results are promising but further comparisons with existing treatments are needed.
Coverage timeline — 1 article
STAT News
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
2026-06-08 20:15 UTC